Full Name
William Kenneth Redekop
(not current staff)
 
 
Email
ephwkrp@nus.edu.sg
 
Other emails
 

Publications

Results 1-13 of 13 (Search time: 0.011 seconds).

Issue DateTitleAuthor(s)
12015A conceptual disease model for adult Pompe disease Inherited metabolic diseasesKanters, T.A; Redekop, W.K ; Rutten-Van Mölken, M.P.M.H; Kruijshaar, M.E; Güngör, D; Van Der Ploeg, A.T; Hakkaart, L
22005Blood pressure patterns in rural, semi-urban and urban children in the Ashanti region of Ghana, West AfricaAgyemang, C; Redekop, W.K ; Owusu-Dabo, E; Bruijnzeels, M.A
32016Concerted Efforts to Control or Eliminate Neglected Tropical Diseases: How Much Health Will Be Gained?de Vlas S.J.; Stolk W.A.; le Rutte E.A.; Hontelez J.A.C.; Bakker R.; Blok D.J.; Cai R.; Houweling T.A.J.; Kulik M.C.; Lenk E.J.; Luyendijk M.; Matthijsse S.M.; Redekop W.K. ; Wagenaar I.; Jacobson J.; Nagelkerke N.J.D.; Richardus J.H.
42014Cost-effectiveness of enzyme replacement therapy with alglucosidase alfa in classic-infantile patients with Pompe diseaseKanters, T.A; Hoogenboom-Plug, I; Rutten-Van Mölken, M.P; Redekop, W.K ; Van Der Ploeg, A.T; Hakkaart, L
52015Cost-effectiveness of including a nurse specialist in the treatment of urinary incontinence in primary care in the NetherlandsHoltzer-Goor K.M.; Gaultney J.G.; Van Houten P.; Wagg A.S.; Huygens S.A.; Nielen M.M.J.; Albers-Heitner C.P.; Redekop W.K. ; Rutten-Van Mölken M.P.; Al M.J.
62014Patient perspective on remote monitoring of cardiovascular implantable electronic devices: Rationale and design of the REMOTE-CIED studyVersteeg, H; Pedersen, S.S; Mastenbroek, M.H; Redekop, W.K ; Schwab, J.O; Mabo, P; Meine, M
72016Productivity Loss Related to Neglected Tropical Diseases Eligible for Preventive Chemotherapy: A Systematic Literature ReviewLenk E.J.; Redekop W.K. ; Luyendijk M.; Rijnsburger A.J.; Severens J.L.
82014Step-by-step guideline for disease-specific costing studies in low- and middle-income countries: A mixed methodologyHendriks, M.E; Kundu, P; Boers, A.C; Bolarinwa, O.A; te Pas, M.J; Akande, T.M; Agbede, K; Gomez, G.B; Redekop, W.K ; Schultsz, C; Tan, S.S
92013Systematic review of available evidence on 11 high-priced inpatient orphan drugsKanters, T.A; De Sonneville-Koedoot, C; Redekop, W.K ; Hakkaart, L
102017The Socioeconomic Benefit to Individuals of Achieving the 2020 Targets for Five Preventive Chemotherapy Neglected Tropical DiseasesRedekop W.K. ; Lenk E.J.; Luyendijk M.; Fitzpatrick C.; Niessen L.; Stolk W.A.; Tediosi F.; Rijnsburger A.J.; Bakker R.; Hontelez J.A.C.; Richardus J.H.; Jacobson J.; de Vlas S.J.; Severens J.L.
112016Treatment variation in stent choice in patients with stable or unstable coronary artery diseaseBurgers, L.T; McClellan, E.A; Hoefer, I.E; Pasterkamp, G; Jukema, J.W; Horsman, S; Pijls, N.H.J; Waltenberger, J; Hillaert, M.A; Stubbs, A.C; Severens, J.L; Redekop, W.K 
122016Using meta-regression analyses in addition to conventional systematic review methods to examine the variation in cost-effectiveness results - A case study Utilization, expenditure, economics and financing systemsBurgers, L.T; Van De Wetering, F.T; Severens, J.L; Redekop, W.K 
132016Variation in use of targeted therapies for metastatic renal cell carcinoma: Results from a Dutch population-based registryDe Groot, S; Sleijfer, S; Redekop, W.K ; Oosterwijk, E; Haanen, J.B.A.G; Kiemeney, L.A.L.M; Uyl-de Groot, C.A